Covid vaccine boost: Serum Institute founder adds $3.6 billion to his wealth in just under 4 months
The AstraZeneca-Oxford vaccine candidate deal has progressed to Phase-III trials and their Covidshield vaccine is getting government permission to manufacture the immunisation.
No comments:
Post a Comment